[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569185":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":47,"collaborators":50,"id":52,"slug":10,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":57,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":64,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":72,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic Test: Single Group Assignment",null,"Each subject receive a single intravenous injection of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3 , and undergo PET\u002FCT imaging within the specificed time.",[13],"Diagnostic Test: 68Ga\u002F18F-TATE\u002FJR11\u002FLM3",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","68Ga\u002F18F-TATE\u002FJR11\u002FLM3","Each subject receive a single intravenous injection of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3, and undergo PET\u002FCT imaging within the specificed time.",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Haonan Yu, MD","CONTACT","+8613821000597","dreamadam@126.com",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Shaobo Yao, PhD","+8615122570279","yaoshaobo008@163.com",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"Tianjin Medical University General Hospital","RECRUITING","Tianjin","Tianjin Municipality","300052","China","CN",{"type":40,"coordinates":41},"Point",[42,43],117.17667,39.14222,{"lat":43,"lon":42},[46],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"type":48,"investigatorFullName":27,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Prof.",[51],{"name":32,"class":6},"100569185",false,"NCT06690957","Somatostatin Receptor PET\u002FCT in SSTR-Related Disease Patients","Inclusion Criteria:\n\n\\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled SSTR PET\u002FCT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n\\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","80 Years",{"count":62,"type":63},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 68Ga\u002F18F-TATE\u002FJR11\u002FLM3 positron emission tomography\u002Fcomputed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various SSTR-related disease patients.",[68,69,70,71],"SSTR-related Disease","Tumor","Positron Emission Tomography","Metastasis",[73,74,75,76],"PET\u002FCT","SSTR","Angonist","Antagonist","2025-02-07",{"date":79,"type":80},"2025-02-11","ACTUAL",{"date":82,"type":80},"2019-02-01",{"date":84,"type":63},"2027-10-01",{"name":5,"class":6},1]